Patterns and processes of somatic mutations in nine major cancers
Peilin Jia , William Pao , Zhongming Zhao
BMC Medical Genomics 7 ( 1) 11 -11
52
2014
Epidermal Growth Factor Receptor Mutations, Small-Molecule Kinase Inhibitors, and Non–Small-Cell Lung Cancer: Current Knowledge and Future Directions
William Pao , Vincent A. Miller
Journal of Clinical Oncology 23 ( 11) 2556 -2568
811
2005
Systematic screen for tyrosine kinase rearrangements identifies a novel C6orf204‐PDGFRB fusion in a patient with recurrent T‐ALL and an associated myeloproliferative neoplasm
Juliann Chmielecki , Martin Peifer , Agnes Viale , Katherine Hutchinson
Genes, Chromosomes and Cancer 51 ( 1) 54 -65
19
2012
Disparities by Race, Age, and Sex in the Improvement of Survival for Major Cancers: Results From the National Cancer Institute Surveillance, Epidemiology, and End Results (SEER) Program in the United States, 1990 to 2010.
Chenjie Zeng , Wanqing Wen , Alicia K Morgans , William Pao
JAMA Oncology 1 ( 1) 88 -96
167
2015
Intrathymic δ Selection Events in γδ Cell Development
Lorena Passoni , Eric S Hoffman , Sylvia Kim , Tessa Crompton
Immunity 7 ( 1) 83 -95
99
1997
Genetically informed lung cancer medicine
William Pao , A John Iafrate , Zengliu Su
The Journal of Pathology 223 ( 2) 231 -241
55
2011
Mutational Analysis of EGFR and Related Signaling Pathway Genes in Lung Adenocarcinomas Identifies a Novel Somatic Kinase Domain Mutation in FGFR4
Jenifer L. Marks , Michael D. McLellan , Maureen F. Zakowski , Alex E. Lash
PLOS ONE 2 ( 5)
111
2007
Tumor Progression Stage and Anatomical Site Regulate Tumor-Associated Macrophage and Bone Marrow-Derived Monocyte Polarization
Elizabeth F. Redente , Lori D. Dwyer-Nield , Daniel T. Merrick , Komal Raina
American Journal of Pathology 176 ( 6) 2972 -2985
106
2010
EGFR Mutations in Lung Adenocarcinomas: Clinical Testing Experience and Relationship to EGFR Gene Copy Number and Immunohistochemical Expression
Allan R. Li , Dhananjay Chitale , Gregory J. Riely , William Pao
The Journal of Molecular Diagnostics 10 ( 3) 242 -248
234
2008
Molecular study of malignant gliomas treated with epidermal growth factor receptor inhibitors: tissue analysis from North American Brain Tumor Consortium Trials 01-03 and 00-01.
Andrew B. Lassman , Michael R. Rossi , Jeffrey R. Razier , Lauren E. Abrey
Clinical Cancer Research 11 ( 21) 7841 -7850
217
2005
Clinical Course of Patients with Non–Small Cell Lung Cancer and Epidermal Growth Factor Receptor Exon 19 and Exon 21 Mutations Treated with Gefitinib or Erlotinib
Gregory J. Riely , William Pao , DuyKhanh Pham , Allan R. Li
Clinical Cancer Research 12 ( 3) 839 -844
837
2006
Update on Epidermal Growth Factor Receptor Mutations in Non–Small Cell Lung Cancer
Gregory J. Riely , Katerina A. Politi , Vincent A. Miller , William Pao
Clinical Cancer Research 12 ( 24) 7232 -7241
332
2006
Novel D761Y and Common Secondary T790M Mutations in Epidermal Growth Factor Receptor–Mutant Lung Adenocarcinomas with Acquired Resistance to Kinase Inhibitors
Marissa N. Balak , Yixuan Gong , Gregory J. Riely , Romel Somwar
Clinical Cancer Research 12 ( 21) 6494 -6501
937
2006
A Pilot Study of Volume Measurement as a Method of Tumor Response Evaluation to Aid Biomarker Development
William Pao , Pingzhen Guo , Valerie M. Rusch , Marc Ladanyi
Clinical Cancer Research 16 ( 18) 4647 -4653
83
2010
Analysis of Tumor Specimens at the Time of Acquired Resistance to EGFR-TKI Therapy in 155 Patients with EGFR-Mutant Lung Cancers
Helena A. Yu , Maria E. Arcila , Natasha Rekhtman , Camelia S. Sima
Clinical Cancer Research 19 ( 8) 2240 -2247
1,407
2013
Characteristics of Lung Cancers Harboring NRAS Mutations
Kadoaki Ohashi , Lecia V. Sequist , Maria E. Arcila , Christine M. Lovly
Clinical Cancer Research 19 ( 9) 2584 -2591
156
2013
Maintained sensitivity to EGFR tyrosine kinase inhibitors in EGFR-mutant lung cancer recurring after adjuvant erlotinib or gefitinib.
Yelena Y. Janjigian , Maria E. Arcila , Camelia S. Sima , Samantha L. Kass
Clinical Cancer Research 17 ( 19) 6322 -6328
43
2011
ALK Mutations Conferring Differential Resistance to Structurally Diverse ALK Inhibitors
Johannes M. Heuckmann , Michael Hölzel , Martin L. Sos , Stefanie Heynck
Clinical Cancer Research 17 ( 23) 7394 -7401
141
2011
Frequency of Driver Mutations in Lung Adenocarcinoma from Female Never-Smokers Varies with Histologic Subtypes and Age at Diagnosis
Yang Zhang , Yihua Sun , Yunjian Pan , Chenguang Li
Clinical Cancer Research 18 ( 7) 1947 -1953
131
2012
Differential Protein Stability and ALK Inhibitor Sensitivity of EML4-ALK Fusion Variants
Johannes M. Heuckmann , Hyatt Balke-Want , Florian Malchers , Martin Peifer
Clinical Cancer Research 18 ( 17) 4682 -4690
179
2012